Document is current
Any future updates will be listed below
-
Authors
Zhang, Chaoting
Liu, Ting
Li, Shance
Teng, Xia
Zhu, Yuge
Zhang, Guanyu
Xie, Huimin
Sun, Kang
Tu, Jiaxin
Yang, Wenjun
Lu, Zheming
-
Funding
Funding for this research was provided by:
Beijing Nova Program (20230484366)
Science Foundation of Peking University Cancer Hospital ([XKFZ2418, BJCH2024GG05])
National Natural Science Foundation of China ([82473320, 82373248, 82160535])
"Open Competition to Select the Best Candidates" Key Technology Program for Nucleic Acid Drugs of NCTIB (NCTIB2023XB02001)
Capital’s Funds for Health Improvement and Research (2022-1-1022)
National Key Research and Development Program of China (2023ZD0501300)
Science and Technology special fund of Hainan Province (ZDYF2024SHF2087)
- License Information
-
More Information
Article History
Received: 5 September 2024
Accepted: 10 October 2024
First Online: 23 October 2024
Declarations
:
: All animal experiments were approved by Experimental Animal Ethics Committee of Peking university Cancer Hospital (EAEC 2018-05).
: Not applicable.
: The authors declare no competing interests.
